Search

You searched for "pharmaceuticals"

133 results found

Théa Pharmaceuticals are excited to be attending RCOphth Congress 2023 with two innovative new products.

22 May 2023 | Research & Development, Awards, Conferences & Anniversaries
This year Théa will also have two stands – one right by the registration desk which will be focused on product sampling and a larger stand inside the main exhibition hall which will showcase the wider product range.

Pharmaceuticals

Jo Cook joins Kimal plc as DXG Specialist for UK

5 August 2021 | Company Profiles, Recruitment & Personnel
Kimal plc is delighted to announce the appointment of Jo Cook to the position of DXG Specialist responsible for the Diagnostic Green range across the UK.

Corporate M&A pace gathers momentum

1 October 2019 | | AMD, Cataract and Refractive, Cornea / External Eye Disease, Emergency Ophthalmology, Genetics, Glaucoma, Imaging, Neuro-Ophthalmology, Ocular Pathology and Oncology, Oculoplastics, Ophthalmology, Optometry, Orbit, Paediatric Ophthalmology / Strabismus, Retina / Uvea / Vitreous
Intensifying franchise competition, maturing product development pipelines and looming loss of exclusivity spur renewed merger and acquisition (M&A) activity in the ophthalmics sector. Rod McNeil reviews recent deals and related strategic developments. AbbVie to acquire Allergan in $63 billion mega-combination,...

Théa launch free communication skills training

8 March 2022 | Recruitment & Personnel, Research & Development
Théa Pharmaceuticals, in collaboration with senior professionals in glaucoma and cornea, has launched seven communication skills courses on their dedicated eye health professional training platform, the Théa Academy, to enhance patient care in response to the increase in remote clinics.

Regulatory drug evaluations and expedited review initiatives: EU and US perspectives

1 April 2016 | | Cataract and Refractive, Cornea / External Eye Disease, Genetics, Glaucoma, Imaging, Neuro-Ophthalmology, Ocular Pathology and Oncology, Oculoplastics, Ophthalmology, Optometry, Orbit, Paediatric Ophthalmology / Strabismus, Retina / Uvea / Vitreous
The European Medicines Agency (EMA) and United States Food and Drug Administration (FDA) each conduct independent assessments of benefit-risk profile when evaluating applications to market new or modified medicines, and their respective decision-making is guided by distinct legislation, procedures and...

Théa launches new, free educational platform!

4 October 2021 | Research & Development
Théa Pharmaceuticals is excited to announce the launch of the Théa Academy, a dedicated platform supporting the education of eye health professionals across the UK.

Entries open for SOC e-poster competition

15 January 2021
The Scottish Ophthalmological Club meeting will take place on 24 February.

SOC (Scottish Ophthalmological Club) Autumn Meeting 2022

16 September 2022
@ 17:30-19:30 pm BST

Glaukos Corporation Inc acquires Avedro Inc

18 December 2019 | Research & Development, Contracts & Distributors
Glaukos Corporation has announced that it has completed its previously announced acquisition of Avedro, Inc.

SOC welcomes registrations and poster submissions for September meeting

27 July 2021
The theme of the Scottish Ophthalmological Club spring meeting on 23 September is ‘Post COVID – The Best of Times and The Worst of Times', featuring eminent speakers on a range of topics.

A Scottish first: SOC goes virtual

28 July 2020
The first virtual Scottish Ophthalmology Club (SOC) meeting will be held on Wednesday 30 September 2020.